Cargando…
Stay on Target: Reengaging Cancer Vaccines in Combination Immunotherapy
Effective treatment of established tumors requires rational multicombination immunotherapy strategies designed to target all functions of the patient immune system and tumor immune microenvironment. While these combinations build on the foundation of successful immune checkpoint blockade antibodies,...
Autores principales: | Wolfson, Benjamin, Franks, S. Elizabeth, Hodge, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156017/ https://www.ncbi.nlm.nih.gov/pubmed/34063388 http://dx.doi.org/10.3390/vaccines9050509 |
Ejemplares similares
-
Natural Born Killers: NK Cells in Cancer Therapy
por: Franks, S. Elizabeth, et al.
Publicado: (2020) -
Activity Disengagement: Understanding Challenges and Opportunities for Reengagement
por: Fox, Krista, et al.
Publicado: (2017) -
Targeting Immunosuppressive Adenosine Signaling: A Review of Potential Immunotherapy Combination Strategies
por: Zahavi, David, et al.
Publicado: (2023) -
Immune targeting of three independent suppressive pathways (TIGIT, PD-L1, TGFβ) provides significant antitumor efficacy in immune checkpoint resistant models
por: Franks, S. Elizabeth, et al.
Publicado: (2022) -
Women of Reproductive Age Living with HIV in Argentina: Unique Challenges for
Reengagement in Care
por: Cecchini, Diego, et al.
Publicado: (2019)